Condition
Tattooing
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed2
Unknown1
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07008339Not ApplicableRecruiting
Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.
NCT06132295Not ApplicableCompleted
Adoption of Multiple Strategies to Reduce the Rate of Marker Detachment During Radiotherapy in Patients With Cancer
NCT05371795Not ApplicableUnknown
Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device
NCT03125824Not ApplicableCompletedPrimary
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol
NCT01516034Not ApplicableTerminatedPrimary
The Efficacy of the Cupola Ultrasonic Tattoo Removal Device
Showing all 5 trials